Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom BurdenFatigue, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Sjogren syndrome, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Xerostomia, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, dry eye syndrome, eye disorder, immune system disorder, lacrimal apparatus disorder, mouth disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis, salivary gland disorderRecruitingPhase 32026-09-28NCT07621809

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Novartis Pharmaceuticals432

18 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Abigail Neiman MD PAHoustonUnited States1
Accurate Clinical ResearchLeague CityUnited States3
Arthritis Care of TexasCorpus ChristiUnited States4
Arthritis Northwest PLLCSpokaneUnited States3
Clinical Res Of W FloridaClearwaterUnited States4
Clinical Research Inst of MISaint Clair ShoresUnited States3
Clinical Research of West Florida IncTampaUnited States2
Novel Research LLCBellaireUnited States13
On Site Clinical Solutions LlcCharlotteUnited States3
Precision Comprehensive Clinical Research SolutionsEulessUnited States3
RAO Research LLCOklahoma CityUnited States6
Shelby Research LLCMemphisUnited States6
St Lawrence Health SystemPotsdamUnited States4
Sun Valley Arthritis Center LtdPeoriaUnited States2
TEKTONLeanderUnited States1
Tufts Medical CenterBostonUnited States238
West Tennessee Research InstituteJacksonUnited States22
Willow Rheumatology WellnessWillowbrookUnited States5